Passive

First Trust International Developed Capital Strength ETF

The First Trust International Developed Capital Strength® ETF (the "Fund") seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an index called The International Developed Capital Strength IndexTM (the "Index").

$42.33

Key Metrics

TER 0.70% per year
Distribution policy Distributing
Fund size USD 214 M
Inception date December 15, 2020
Holdings 52
Fund currency USD
Fund domicile US
Provider First Trust
For full official fund details, factsheets, and holdings, visit ftportfolios.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
International Developed Capital Strength ETF FICS
Fund Size
$214M
Dividend
1.8%
Fees
0.70%
Total Stock Market Index Fund VTSAX
Fund Size
$1.99T
Dividend
1.0%
Fees
0.04%
Total Stock Market Index Fund VTI
Fund Size
$1.99T
Dividend
1.1%
Fees
0.03%
500 Index Fund VFIAX
Fund Size
$1.42T
Dividend
1.0%
Fees
0.04%
500 Index Fund VFINX
Fund Size
$1.42T
Dividend
1.0%
Fees
-
View 1339 similar ETFs →

Historical Return

Last updated: Jul 01, 2026
1 Year +5.9% +1.8% Div
3 Years (avg.) +8.8% +1.8% Div
5 Years (avg.) +3.9% +1.8% Div

Risk & Analysis Metrics

Last updated: Jul 01, 2026

Volatility

12.36% 1 Year
13.00% 3 Years
16.93% 5 Years
16.81% 10 Years

Max Drawdown

-10.77% 1 Year
-11.82% 3 Years
-30.37% 5 Years
-30.37% 10 Years

Sharpe Ratio

0.13 1 Year
0.36 3 Years
0.05 5 Years
0.18 10 Years

Return Triangle (Heatmap)

Last updated: Jul 01, 2026
2020 2021 2022 2023 2024 2025
2020 2.2% 9.0% -2.1% 2.2% 2.1% 4.7%
2021 16.3% -4.2% 2.2% 2.1% 5.2%
2022 -21.1% -4.1% -2.3% 2.6%
2023 16.4% 8.8% 11.9%
2024 1.6% 9.7%
2025 18.5%

Distributions

*by ETF Portfolio Weight Last updated: Jul 01, 2026

Profit Margin Distribution

< 0%
8%
1y 3y N/A N/A
0 - 5%
4%
1y 3y N/A N/A
5 - 10%
21%
1y 3y N/A N/A
10 - 15%
19%
1y 3y N/A N/A
15 - 20%
20%
1y 3y N/A N/A
20 - 30%
15%
1y 3y N/A N/A
30 - 40%
0%
1y 3y N/A N/A
> 40%
13%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
6%
1y 3y N/A N/A
0 - 10
5%
1y 3y N/A N/A
10 - 15
24%
1y 3y N/A N/A
15 - 20
16%
1y 3y N/A N/A
20 - 25
19%
1y 3y N/A N/A
25 - 35
19%
1y 3y N/A N/A
35 - 50
4%
1y 3y N/A N/A
> 50
7%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
9.6%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
12.0%
1y 3y N/A N/A
Large Cap
57.4%
1y 3y N/A N/A
Mega Cap
21.1%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jul 01, 2026
20.2% Top 5 Holdings
37.9% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
IMO Imperial Oil Ltd.
4.7%
RIO Rio Tinto plc
4.2%
BHP BHP Group Limited
3.9%
GSK Glaxosmithkline plc
3.9%
ST Sensata Technologies Holding Plc
3.6%

Latest News

24 days ago • wsj.com

After shedding its cancer business just over a decade ago, GSK's new CEO is building back with a $10.6 billion deal

After shedding its oncology business just over a decade ago, GSK is building it back with a $10.6 billion deal.
24 days ago • zacks.com

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study

Gilead and Merck report positive phase III results for once-weekly HIV regimen islatravir/lenacapavir, while ending a lung cancer study.
24 days ago • zacks.com

GSK to Strengthen Oncology Pipeline With $10.6B Nuvalent Buyout

GSK buys Nuvalent for $10.6 billion, adding three lung cancer pipeline candidates and expanding its precision oncology presence.

Average metrics of all companies in portfolio

Last updated: Jun 28, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $108B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 2.02% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.76 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 31.42 28.61
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -17.88 -
Profitable Companies 93% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 30.24 18.04
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 3.22 8.09
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 4.05 10.18
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 15.16 20.33
Enterprise Value to Revenue Enterprise value divided by revenue 3.96 7.98
Total Debt to Enterprise Value Total debt divided by enterprise value 0.21 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.76 0.27
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 13.99% 20.81%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -14.9% -118.0%
Return on Equity Equity divided by market cap. 19.76% 2.67%
Return on Assets Indicates a company's profitability in relation to its total assets. 7.36% 4.17%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 14.70% 3.72%

Sectors

Finance and Insurance 16.1%
Manufacturing 15.5%
Mining, Quarrying, and Oil and Gas Extraction 8.6%
Health Technology 4.6%
Information 2.8%
Retail Trade 2.1%
Consumer Non-Durables 1.6%
Other 48.7%

Countries

Other 74.1%
Switzerland 23.8%
Ireland 2.1%

Stock Screener

Select filters to narrow down the 32 investments below

32 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
P/E Ratio
Dividends Ratio of dividends in the last 12 months to current share price
Total Investment
Weight

Imperial Oil Ltd.

IMO - Manufacturing

Imperial Oil Ltd.

IMO - Manufacturing
Market Cap $56.31B
P/E Ratio 25.7
Dividends 2.0%
Total Investment $6.53M
Weight 3.05%

Loading details…

Rio Tinto plc - ADR

RIO - Mining, Quarrying, and Oil and Gas Extraction

Rio Tinto plc - ADR

RIO - Mining, Quarrying, and Oil and Gas Extraction
Market Cap $152.24B
P/E Ratio 15.4
Dividends 4.2%
Total Investment $5.8M
Weight 2.71%

Loading details…

BHP Group Limited - ADR

BHP - Mining, Quarrying, and Oil and Gas Extraction

BHP Group Limited - ADR

BHP - Mining, Quarrying, and Oil and Gas Extraction
Market Cap $205.82B
P/E Ratio 20.0
Dividends 3.3%
Total Investment $5.41M
Weight 2.53%

Loading details…

GSK Plc - ADR

GSK - Manufacturing

GSK Plc - ADR

GSK - Manufacturing
Market Cap $105.2B
P/E Ratio 13.7
Dividends 3.4%
Total Investment $5.35M
Weight 2.50%

Loading details…

Sensata Technologies Holding Plc

ST - Manufacturing

Sensata Technologies Holding Plc

ST - Manufacturing
Market Cap $6.8B
P/E Ratio 137.4
Dividends 1.0%
Total Investment $5.01M
Weight 2.34%

Loading details…

Toronto Dominion Bank

TD - Finance and Insurance

Toronto Dominion Bank

TD - Finance and Insurance
Market Cap $202.1B
P/E Ratio 20.0
Dividends 2.5%
Total Investment $4.99M
Weight 2.33%

Loading details…

Novartis AG - ADR

NVS - Health Technology

Novartis AG - ADR

NVS - Health Technology
Market Cap $296.54B
P/E Ratio 22.3
Dividends 2.9%
Total Investment $4.93M
Weight 2.31%

Loading details…

Astrazeneca plc - ADR

AZN - Health Technology

Astrazeneca plc - ADR

AZN - Health Technology
Market Cap $294.4B
P/E Ratio 28.0
Dividends 1.6%
Total Investment $4.91M
Weight 2.30%

Loading details…

ETF Series Solutions Trust - ESS AlphaClone Alternative Alpha ETF

ALFA

ETF Series Solutions Trust - ESS AlphaClone Alternative Alpha ETF

ALFA
Market Cap $58.21B
P/E Ratio
Dividends
Total Investment $4.88M
Weight 2.28%

Loading details…

Deutsche Boerse AG - ADR

DBOEY - Finance and Insurance

Deutsche Boerse AG - ADR

DBOEY - Finance and Insurance
Market Cap $49.24B
P/E Ratio 21.2
Dividends 1.8%
Total Investment $4.77M
Weight 2.23%

Loading details…

Roper Technologies Inc

ROP - Manufacturing

Roper Technologies Inc

ROP - Manufacturing
Market Cap $34.14B
P/E Ratio 21.0
Dividends 1.0%
Total Investment $4.71M
Weight 2.20%

Loading details…

Royal Bank Of Canada

RY - Finance and Insurance

Royal Bank Of Canada

RY - Finance and Insurance
Market Cap $281.92B
P/E Ratio 18.7
Dividends 2.2%
Total Investment $4.7M
Weight 2.20%

Loading details…

Eaton Vance New York Municipal Bond Fund

ENX

Eaton Vance New York Municipal Bond Fund

ENX
Market Cap $179.61M
P/E Ratio -25.0
Dividends 1.7%
Total Investment $4.65M
Weight 2.17%

Loading details…

Loews Corp.

L - Finance and Insurance

Loews Corp.

L - Finance and Insurance
Market Cap $23.3B
P/E Ratio 14.4
Dividends 0.2%
Total Investment $4.57M
Weight 2.14%

Loading details…

Prudential Financial Inc.

PRU - Finance and Insurance

Prudential Financial Inc.

PRU - Finance and Insurance
Market Cap $37.6B
P/E Ratio 11.0
Dividends 5.1%
Total Investment $4.42M
Weight 2.07%

Loading details…

Industria De Diseno Textil SA - ADR

IDEXY - Retail Trade

Industria De Diseno Textil SA - ADR

IDEXY - Retail Trade
Market Cap $198.33B
P/E Ratio 27.7
Dividends 3.1%
Total Investment $4.42M
Weight 2.06%

Loading details…

Autoliv Inc.

ALV - Manufacturing

Autoliv Inc.

ALV - Manufacturing
Market Cap $8.92B
P/E Ratio 12.7
Dividends 2.9%
Total Investment $4.4M
Weight 2.06%

Loading details…

Ferrovial S.E.

FER

Ferrovial S.E.

FER
Market Cap $49.26B
P/E Ratio 49.0
Dividends 1.7%
Total Investment $4.37M
Weight 2.04%

Loading details…

Invesco Capital Management LLC - PowerShares UltraShort Lehman 7-10 + Year Treasury ProShares -2X Sh

PST

Invesco Capital Management LLC - PowerShares UltraShort Lehman 7-10 + Year Treasury ProShares -2X Sh

PST
Market Cap $491.05B
P/E Ratio
Dividends 2.9%
Total Investment $4.28M
Weight 2.00%

Loading details…

Zurich Insurance Group AG Ltd - ADR

ZURVY - Finance and Insurance

Zurich Insurance Group AG Ltd - ADR

ZURVY - Finance and Insurance
Market Cap $108.53B
P/E Ratio 12.6
Dividends 5.1%
Total Investment $4.26M
Weight 1.99%

Loading details…